{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:57:31Z","timestamp":1783432651546,"version":"3.54.6"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL139778"],"award-info":[{"award-number":["R01HL139778"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL150040"],"award-info":[{"award-number":["R01HL150040"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL163196"],"award-info":[{"award-number":["R01HL163196"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL144436"],"award-info":[{"award-number":["R01HL144436"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL163196"],"award-info":[{"award-number":["R01HL163196"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-17-1-0429"],"award-info":[{"award-number":["W81XWH-17-1-0429"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-17-1-0429"],"award-info":[{"award-number":["W81XWH-17-1-0429"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"DOI":"10.1038\/s44161-024-00550-9","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T07:03:15Z","timestamp":1730444595000},"page":"1301-1317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia"],"prefix":"10.1038","volume":"3","author":[{"given":"Sajeth","family":"Dinakaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6254-5759","authenticated-orcid":false,"given":"Sima","family":"Qutaina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2626-6160","authenticated-orcid":false,"given":"Santiago","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7733-5122","authenticated-orcid":false,"given":"Aya","family":"Nomura-Kitabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1013-1691","authenticated-orcid":false,"given":"Christine N.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M.","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stryder M.","family":"Meadows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0185-6260","authenticated-orcid":false,"given":"Lionel","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie E.","family":"Faughnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8983-1497","authenticated-orcid":false,"given":"Philippe","family":"Marambaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"550_CR1","doi-asserted-by":"publisher","first-page":"989","DOI":"10.7326\/M20-1443","volume":"173","author":"ME Faughnan","year":"2020","unstructured":"Faughnan, M. E. et al. Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. Ann. Intern. Med. 173, 989\u20131001 (2020).","journal-title":"Ann. Intern. Med."},{"key":"550_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/path.4844","volume":"241","author":"SE Wetzel-Strong","year":"2017","unstructured":"Wetzel-Strong, S. E., Detter, M. R. & Marchuk, D. A. The pathobiology of vascular malformations: insights from human and model organism genetics. J. Pathol. 241, 281\u2013293 (2017).","journal-title":"J. Pathol."},{"key":"550_CR3","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1177\/1535370219881160","volume":"244","author":"SK Kim","year":"2019","unstructured":"Kim, S. K., Henen, M. A. & Hinck, A. P. Structural biology of betaglycan and endoglin, membrane-bound co-receptors of the TGF-beta family. Exp. Biol. Med. 244, 1547\u20131558 (2019).","journal-title":"Exp. Biol. Med."},{"key":"550_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1002\/dvdy.395","volume":"251","author":"A Desroches-Castan","year":"2022","unstructured":"Desroches-Castan, A., Tillet, E., Bouvard, C. & Bailly, S. BMP9 and BMP10: two close vascular quiescence partners that stand out. Dev. Dyn. 251, 178\u2013197 (2022).","journal-title":"Dev. Dyn."},{"key":"550_CR5","doi-asserted-by":"publisher","first-page":"973964","DOI":"10.3389\/fmed.2022.973964","volume":"9","author":"HM Arthur","year":"2022","unstructured":"Arthur, H. M. & Roman, B. L. An update on preclinical models of hereditary haemorrhagic telangiectasia: insights into disease mechanisms. Front. Med. 9, 973964 (2022).","journal-title":"Front. Med."},{"key":"550_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41569-021-00517-4","volume":"18","author":"N Ricard","year":"2021","unstructured":"Ricard, N., Bailly, S., Guignabert, C. & Simons, M. The quiescent endothelium: signalling pathways regulating organ-specific endothelial normalcy. Nat. Rev. Cardiol. 18, 565\u2013580 (2021).","journal-title":"Nat. Rev. Cardiol."},{"key":"550_CR7","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.ajhg.2019.09.010","volume":"105","author":"DA Snellings","year":"2019","unstructured":"Snellings, D. A. et al. Somatic mutations in vascular malformations of hereditary hemorrhagic telangiectasia result in bi-allelic loss of ENG or ACVRL1. Am. J. Hum. Genet. 105, 894\u2013906 (2019).","journal-title":"Am. J. Hum. Genet."},{"key":"550_CR8","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","volume":"106","author":"H Al-Samkari","year":"2021","unstructured":"Al-Samkari, H. et al. An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study. Haematologica 106, 2161\u20132169 (2021).","journal-title":"Haematologica"},{"key":"550_CR9","doi-asserted-by":"publisher","first-page":"104575","DOI":"10.1016\/j.ejmg.2022.104575","volume":"65","author":"S Dupuis-Girod","year":"2022","unstructured":"Dupuis-Girod, S. et al. European Reference Network for Rare Vascular Diseases (VASCERN): when and how to use intravenous bevacizumab in hereditary haemorrhagic telangiectasia (HHT)? Eur. J. Med. Genet. 65, 104575 (2022).","journal-title":"Eur. J. Med. Genet."},{"key":"550_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep37366","volume":"5","author":"S Ruiz","year":"2016","unstructured":"Ruiz, S. et al. A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10. Sci. Rep. 5, 37366 (2016).","journal-title":"Sci. Rep."},{"key":"550_CR11","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1093\/hmg\/ddx358","volume":"26","author":"S Ruiz","year":"2017","unstructured":"Ruiz, S. et al. Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology. Hum. Mol. Genet. 26, 4786\u20134798 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"550_CR12","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1172\/JCI127425","volume":"130","author":"S Ruiz","year":"2020","unstructured":"Ruiz, S. et al. Correcting Smad1\/5\/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models. J. Clin. Invest. 130, 942\u2013957 (2020).","journal-title":"J. Clin. Invest."},{"key":"550_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1281-4","volume":"15","author":"F Robert","year":"2020","unstructured":"Robert, F., Desroches-Castan, A., Bailly, S., Dupuis-Girod, S. & Feige, J.-J. Future treatments for hereditary hemorrhagic telangiectasia. Orphanet J. Rare Dis. 15, 4 (2020).","journal-title":"Orphanet J. Rare Dis."},{"key":"550_CR14","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1007\/s00018-017-2636-4","volume":"74","author":"BL Roman","year":"2017","unstructured":"Roman, B. L. & Hinck, A. P. ALK1 signaling in development and disease: new paradigms. Cell. Mol. Life Sci. 74, 4539\u20134560 (2017).","journal-title":"Cell. Mol. Life Sci."},{"key":"550_CR15","doi-asserted-by":"publisher","first-page":"eaal2379","DOI":"10.1126\/science.aal2379","volume":"357","author":"HG Augustin","year":"2017","unstructured":"Augustin, H. G. & Koh, G. Y. Organotypic vasculature: from descriptive heterogeneity to functional pathophysiology. Science 357, eaal2379 (2017).","journal-title":"Science"},{"key":"550_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nrm.2017.36","volume":"18","author":"M Potente","year":"2017","unstructured":"Potente, M. & M\u00e4kinen, T. Vascular heterogeneity and specialization in development and disease. Nat. Rev. Mol. Cell Biol. 18, 477\u2013494 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"550_CR17","doi-asserted-by":"publisher","first-page":"eabc1495","DOI":"10.1126\/science.abc1495","volume":"375","author":"A Fassl","year":"2022","unstructured":"Fassl, A., Geng, Y. & Sicinski, P. CDK4 and CDK6 kinases: from basic science to cancer therapy. Science 375, eabc1495 (2022).","journal-title":"Science"},{"key":"550_CR18","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1093\/hmg\/ddm069","volume":"16","author":"A Fernandez-L","year":"2007","unstructured":"Fernandez-L, A. et al. Gene expression fingerprinting for human hereditary hemorrhagic telangiectasia. Hum. Mol. Genet. 16, 1515\u20131533 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"550_CR19","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1182\/blood.V100.13.4495","volume":"100","author":"S Lamouille","year":"2002","unstructured":"Lamouille, S., Mallet, C., Feige, J.-J. & Bailly, S. Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis. Blood 100, 4495\u20134501 (2002).","journal-title":"Blood"},{"key":"550_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13650","volume":"7","author":"R Ola","year":"2016","unstructured":"Ola, R. et al. PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia. Nat. Commun. 7, 13650 (2016).","journal-title":"Nat. Commun."},{"key":"550_CR21","doi-asserted-by":"publisher","first-page":"9385","DOI":"10.1073\/pnas.170282597","volume":"97","author":"K Lin","year":"2000","unstructured":"Lin, K. et al. Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc. Natl Acad. Sci. USA 97, 9385\u20139389 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"550_CR22","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/cvr\/cvm095","volume":"77","author":"Z Han","year":"2008","unstructured":"Han, Z. et al. Aryl hydrocarbon receptor mediates laminar fluid shear stress-induced CYP1A1 activation and cell cycle arrest in vascular endothelial cells. Cardiovasc. Res. 77, 809\u2013818 (2008).","journal-title":"Cardiovasc. Res."},{"key":"550_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01742-7","volume":"8","author":"JS Fang","year":"2017","unstructured":"Fang, J. S. et al. Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nat. Commun. 8, 2149 (2017).","journal-title":"Nat. Commun."},{"key":"550_CR24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1083\/jcb.201603106","volume":"214","author":"N Baeyens","year":"2016","unstructured":"Baeyens, N. et al. Defective fluid shear stress mechanotransduction mediates hereditary hemorrhagic telangiectasia. J. Cell Biol. 214, 807\u2013816 (2016).","journal-title":"J. Cell Biol."},{"key":"550_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-4939-0888-2_7","volume":"1170","author":"E Cuy\u00e0s","year":"2014","unstructured":"Cuy\u00e0s, E., Corominas-Faja, B., Joven, J. & Menendez, J. A. Cell cycle regulation by the nutrient-sensing mammalian target of rapamycin (mTOR) pathway. Methods Mol. Biol. 1170, 113\u2013144 (2014).","journal-title":"Methods Mol. Biol."},{"key":"550_CR26","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1161\/ATVBAHA.118.310760","volume":"38","author":"E Alsina-Sanch\u00eds","year":"2018","unstructured":"Alsina-Sanch\u00eds, E. et al. ALK1 loss results in vascular hyperplasia in mice and humans through PI3K activation. Arterioscler. Thromb. Vasc. Biol. 38, 1216\u20131229 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"550_CR27","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1161\/CIRCRESAHA.107.165530","volume":"102","author":"L David","year":"2008","unstructured":"David, L. et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ. Res. 102, 914\u2013922 (2008).","journal-title":"Circ. Res."},{"key":"550_CR28","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1242\/jcs.002949","volume":"120","author":"M Scharpfenecker","year":"2007","unstructured":"Scharpfenecker, M. et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J. Cell Sci. 120, 964\u2013972 (2007).","journal-title":"J. Cell Sci."},{"key":"550_CR29","doi-asserted-by":"publisher","first-page":"e98646","DOI":"10.1371\/journal.pone.0098646","volume":"9","author":"S Tual-Chalot","year":"2014","unstructured":"Tual-Chalot, S. et al. Endothelial depletion of Acvrl1 in mice leads to arteriovenous malformations associated with reduced endoglin expression. PLoS ONE 9, e98646 (2014).","journal-title":"PLoS ONE"},{"key":"550_CR30","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1161\/CIRCRESAHA.109.211037","volume":"106","author":"M Mahmoud","year":"2010","unstructured":"Mahmoud, M. et al. Pathogenesis of arteriovenous malformations in the absence of endoglin. Circ. Res. 106, 1425\u20131433 (2010).","journal-title":"Circ. Res."},{"key":"550_CR31","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10456-018-9602-0","volume":"21","author":"AM Crist","year":"2018","unstructured":"Crist, A. M., Lee, A. R., Patel, N. R., Westhoff, D. E. & Meadows, S. M. Vascular deficiency of Smad4 causes arteriovenous malformations: a mouse model of hereditary hemorrhagic telangiectasia. Angiogenesis 21, 363\u2013380 (2018).","journal-title":"Angiogenesis"},{"key":"550_CR32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/ncb3534","volume":"19","author":"Y Jin","year":"2017","unstructured":"Jin, Y. et al. Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling. Nat. Cell Biol. 19, 639\u2013652 (2017).","journal-title":"Nat. Cell Biol."},{"key":"550_CR33","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1161\/CIRCULATIONAHA.118.033842","volume":"138","author":"R Ola","year":"2018","unstructured":"Ola, R. et al. SMAD4 prevents flow induced arteriovenous malformations by inhibiting casein kinase 2. Circulation 138, 2379\u20132394 (2018).","journal-title":"Circulation"},{"key":"550_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10456-022-09859-0","volume":"26","author":"H Choi","year":"2022","unstructured":"Choi, H. et al. BMP10 functions independently from BMP9 for the development of a proper arteriovenous network. Angiogenesis 26, 167\u2013186 (2022).","journal-title":"Angiogenesis"},{"key":"550_CR35","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F","volume":"173","author":"JR Nevins","year":"1997","unstructured":"Nevins, J. R., Leone, G., DeGregori, J. & Jakoi, L. Role of the Rb\/E2F pathway in cell growth control. J. Cell. Physiol. 173, 233\u2013236 (1997).","journal-title":"J. Cell. Physiol."},{"key":"550_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1083\/jcb.149.2.271","volume":"149","author":"H Leonhardt","year":"2000","unstructured":"Leonhardt, H. et al. Dynamics of DNA replication factories in living cells. J. Cell Biol. 149, 271\u2013280 (2000).","journal-title":"J. Cell Biol."},{"key":"550_CR37","doi-asserted-by":"publisher","first-page":"e1700298","DOI":"10.1126\/sciadv.1700298","volume":"3","author":"Y Hwang","year":"2017","unstructured":"Hwang, Y. et al. Global increase in replication fork speed during a p57KIP2-regulated erythroid cell fate switch. Sci. Adv. 3, e1700298 (2017).","journal-title":"Sci. Adv."},{"key":"550_CR38","doi-asserted-by":"publisher","first-page":"107804","DOI":"10.1016\/j.celrep.2020.107804","volume":"31","author":"AE Eastman","year":"2020","unstructured":"Eastman, A. E. et al. Resolving cell cycle speed in one snapshot with a live-cell fluorescent reporter. Cell Rep. 31, 107804 (2020).","journal-title":"Cell Rep."},{"key":"550_CR39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.cell.2020.01.015","volume":"180","author":"J Kalucka","year":"2020","unstructured":"Kalucka, J. et al. Single-cell transcriptome atlas of murine endothelial cells. Cell 180, 764\u2013779.e20 (2020).","journal-title":"Cell"},{"key":"550_CR40","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrclinonc.2016.26","volume":"13","author":"B O\u2019Leary","year":"2016","unstructured":"O\u2019Leary, B., Finn, R. S. & Turner, N. C. Treating cancer with selective CDK4\/6 inhibitors. Nat. Rev. Clin. Oncol. 13, 417\u2013430 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"550_CR41","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10555-020-09885-8","volume":"39","author":"GP Sava","year":"2020","unstructured":"Sava, G. P., Fan, H., Coombes, R. C., Buluwela, L. & Ali, S. CDK7 inhibitors as anticancer drugs. Cancer Metastasis Rev. 39, 805\u2013823 (2020).","journal-title":"Cancer Metastasis Rev."},{"key":"550_CR42","unstructured":"McDonald, J. & Stevenson, D. A. Hereditary hemorrhagic telangiectasia. in GeneReviews (eds Adam, M. P. et al.) www.ncbi.nlm.nih.gov\/books\/NBK1351 (Univ. Washington, 2000)."},{"key":"550_CR43","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1161\/ATVBAHA.123.319385","volume":"43","author":"X Zhou","year":"2023","unstructured":"Zhou, X. et al. ANG2 blockade diminishes proangiogenic cerebrovascular defects associated with models of hereditary hemorrhagic telangiectasia. Arterioscler. Thromb. Vasc. Biol. 43, 1384\u20131403 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"550_CR44","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tig.2012.11.008","volume":"29","author":"K Beets","year":"2013","unstructured":"Beets, K., Huylebroeck, D., Moya, I. M., Umans, L. & Zwijsen, A. Robustness in angiogenesis: notch and BMP shaping waves. Trends Genet. 29, 140\u2013149 (2013).","journal-title":"Trends Genet."},{"key":"550_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccr.2013.07.012","volume":"24","author":"K Kollmann","year":"2013","unstructured":"Kollmann, K. et al. A kinase-independent function of CDK6 links the cell cycle to tumor angiogenesis. Cancer Cell 24, 167\u2013181 (2013).","journal-title":"Cancer Cell"},{"key":"550_CR46","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1161\/CIRCULATIONAHA.118.036952","volume":"139","author":"AM Crist","year":"2019","unstructured":"Crist, A. M. et al. Angiopoietin-2 inhibition rescues arteriovenous malformation in a Smad4 hereditary hemorrhagic telangiectasia mouse model. Circulation 139, 2049\u20132063 (2019).","journal-title":"Circulation"},{"key":"550_CR47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10456-018-9605-x","volume":"21","author":"M Araki","year":"2018","unstructured":"Araki, M. et al. Serum\/glucocorticoid-regulated kinase 1 as a novel transcriptional target of bone morphogenetic protein-ALK1 receptor signaling in vascular endothelial cells. Angiogenesis 21, 415\u2013423 (2018).","journal-title":"Angiogenesis"},{"key":"550_CR48","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1002\/1873-3468.13901","volume":"594","author":"F Medina-Jover","year":"2020","unstructured":"Medina-Jover, F., Gendrau-Sanclemente, N. & Vi\u00f1als, F. SGK1 is a signalling hub that controls protein synthesis and proliferation in endothelial cells. FEBS Lett. 594, 3200\u20133215 (2020).","journal-title":"FEBS Lett."},{"key":"550_CR49","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1158\/2159-8290.CD-15-0894","volume":"6","author":"CJ Sherr","year":"2016","unstructured":"Sherr, C. J., Beach, D. & Shapiro, G. I. Targeting CDK4 and CDK6: from discovery to therapy. Cancer Discov. 6, 353\u2013367 (2016).","journal-title":"Cancer Discov."},{"key":"550_CR50","doi-asserted-by":"publisher","first-page":"113676","DOI":"10.1016\/j.bcp.2019.113676","volume":"170","author":"M Bonelli","year":"2019","unstructured":"Bonelli, M., La Monica, S., Fumarola, C. & Alfieri, R. Multiple effects of CDK4\/6 inhibition in cancer: from cell cycle arrest to immunomodulation. Biochem. Pharmacol. 170, 113676 (2019).","journal-title":"Biochem. Pharmacol."},{"key":"550_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41586-021-03562-8","volume":"594","author":"AA Ren","year":"2021","unstructured":"Ren, A. A. et al. PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism. Nature 594, 271\u2013276 (2021).","journal-title":"Nature"},{"key":"550_CR52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.hoc.2019.01.011","volume":"33","author":"DM Adams","year":"2019","unstructured":"Adams, D. M. & Ricci, K. W. Vascular anomalies: diagnosis of complicated anomalies and new medical treatment options. Hematol. Oncol. Clin. North Am. 33, 455\u2013470 (2019).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"550_CR53","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12975-021-00955-9","volume":"13","author":"SS Shaligram","year":"2022","unstructured":"Shaligram, S. S. et al. Bone marrow-derived Alk1 mutant endothelial cells and clonally expanded somatic Alk1 mutant endothelial cells contribute to the development of brain arteriovenous malformations in mice. Transl. Stroke Res. 13, 494\u2013504 (2022).","journal-title":"Transl. Stroke Res."},{"key":"550_CR54","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/hep.30424","volume":"69","author":"J Dumortier","year":"2019","unstructured":"Dumortier, J. et al. Recurrence of hereditary hemorrhagic telangiectasia after liver transplantation: clinical implications and physiopathological insights. Hepatology 69, 2232\u20132240 (2019).","journal-title":"Hepatology"},{"key":"550_CR55","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cell.2004.08.002","volume":"118","author":"M Malumbres","year":"2004","unstructured":"Malumbres, M. et al. Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118, 493\u2013504 (2004).","journal-title":"Cell"},{"key":"550_CR56","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41569-022-00770-1","volume":"20","author":"E Trimm","year":"2023","unstructured":"Trimm, E. & Red-Horse, K. Vascular endothelial cell development and diversity. Nat. Rev. Cardiol. 20, 197\u2013210 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"550_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33324-7","volume":"13","author":"NW Chavkin","year":"2022","unstructured":"Chavkin, N. W. et al. Endothelial cell cycle state determines propensity for arterial-venous fate. Nat. Commun. 13, 5891 (2022).","journal-title":"Nat. Commun."},{"key":"550_CR58","doi-asserted-by":"publisher","first-page":"e168352","DOI":"10.1172\/JCI168352","volume":"133","author":"K Banerjee","year":"2023","unstructured":"Banerjee, K. et al. SMAD4 maintains the fluid shear stress set point to protect against arterial-venous malformations. J. Clin. Invest. 133, e168352 (2023).","journal-title":"J. Clin. Invest."},{"key":"550_CR59","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.122.062952","volume":"149","author":"G Genet","year":"2024","unstructured":"Genet, G. et al. Induced endothelial cell cycle arrest prevents arteriovenous malformations in hereditary hemorrhagic telangiectasia. Circulation 149, 944\u2013962 (2024).","journal-title":"Circulation"},{"key":"550_CR60","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00335-012-9422-2","volume":"23","author":"A Bradley","year":"2012","unstructured":"Bradley, A. et al. The mammalian gene function resource: the International Knockout Mouse Consortium. Mamm. Genome 23, 580\u2013586 (2012).","journal-title":"Mamm. Genome"},{"key":"550_CR61","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/dvg.20284","volume":"45","author":"KR Allinson","year":"2007","unstructured":"Allinson, K. R., Carvalho, R. L. C., van den Brink, S., Mummery, C. L. & Arthur, H. M. Generation of a floxed allele of the mouse endoglin gene. Genesis 45, 391\u2013395 (2007).","journal-title":"Genesis"},{"key":"550_CR62","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1182\/blood-2008-08-174508","volume":"113","author":"I S\u00f6rensen","year":"2009","unstructured":"S\u00f6rensen, I., Adams, R. H. & Gossler, A. DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries. Blood 113, 5680\u20135688 (2009).","journal-title":"Blood"},{"key":"550_CR63","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s13023-022-02539-8","volume":"17","author":"KP Thompson","year":"2022","unstructured":"Thompson, K. P. et al. Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia. Orphanet J. Rare Dis. 17, 405 (2022).","journal-title":"Orphanet J. Rare Dis."},{"key":"550_CR64","doi-asserted-by":"publisher","first-page":"e20230018","DOI":"10.1084\/jem.20230018","volume":"220","author":"T Song","year":"2023","unstructured":"Song, T. et al. Host factor TIMP1 sustains long-lasting myeloid-biased hematopoiesis after severe infection. J. Exp. Med. 220, e20230018 (2023).","journal-title":"J. Exp. Med."},{"key":"550_CR65","unstructured":"Elfarnawany, M. H. Signal Processing Methods for Quantitative Power Doppler Microvascular Angiography. PhD thesis, Western Univ. (2015)."},{"key":"550_CR66","doi-asserted-by":"publisher","first-page":"C1294","DOI":"10.1152\/ajpcell.00160.2009","volume":"297","author":"PK Chatterjee","year":"2009","unstructured":"Chatterjee, P. K., Al-Abed, Y., Sherry, B. & Metz, C. N. Cholinergic agonists regulate JAK2\/STAT3 signaling to suppress endothelial cell activation. Am. J. Physiol. Cell Physiol. 297, C1294\u2013C1306 (2009).","journal-title":"Am. J. Physiol. Cell Physiol."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00550-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00550-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00550-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T19:04:07Z","timestamp":1731351847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-024-00550-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":66,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["550"],"URL":"https:\/\/doi.org\/10.1038\/s44161-024-00550-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.09.15.554413","asserted-by":"object"}]},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"15 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}